SRV Hospitals gets Rs. 140 crore from InvAscent for expansion

hospital

SRV Hospitals secured ₹1.4 billion (₹140 crores) in funding from private equity firm InvAscent to enhance its critical care-focused healthcare model and expand its reach.

Founded in 2015, SRV Hospitals operates five tertiary care facilities with over 500 beds across Mumbai, Nashik, and Bengaluru.

The group emphasizes consultant-led care, robust critical care systems, and patient experience. The new capital injection will help SRV accelerate its growth, invest in technology, and strengthen its operational systems.

“We built SRV Hospitals with a vision of setting new standards in the critical and surgical care space, and those standards have now become our greatest strength,” Dr. Abhay Vispute, Director at SRV Hospitals, said in a statement. “This investment from InvAscent is a strategic alignment of purpose...This capital will strengthen our core and extend our impact.”

InvAscent, a life sciences private equity fund with over $800 million in assets under management, has previously invested in healthcare brands like HCG Hospitals and Dr. Agarwal’s Eye Hospital.

“Our mission is rooted in the belief that high-quality care should not be a privilege of geography,” stated Sameer Pawar, CEO of SRV Hospitals. “This investment allows us to strengthen our mission responsibly—with our people, our standards, and our commitment to trust at the centre of it all.”

InvAscent highlighted SRV's strong clinical network and leadership as key factors in its investment decision. “We are proud to partner with SRV Hospitals, a group that has a strong foundation and boasts a high-trust clinical network backed by differentiated critical care model, and a leadership team that is not only clinically astute and operationally strong but deeply aligned with the long-term evolution of healthcare in this country,” said Dr. Jeevak Gupta, Director – Investments at InvAscent.